University Medical Center Utrecht
Medical Microbiology
I am a clinician-scientist at the UMC Utrecht (The Netherlands). In my practice as a board-certified clinical microbiologist, I am confronted by increasing resistance of bacteria to antibiotics. Our growing global failure to treat infections could effectively compromise modern medicine as we know it. I perform genetic studies in patients who suffer from severe infectious diseases. My research sheds light on how the individual genetic makeup of humans predisposes them to specific infections. Understanding this predisposition on a molecular level will help to identify innovative and personalized strategies to treat infectious diseases. As a clinician-scientist, I have dedicated my life to combining my clinical expertise and skills in fundamental biomedical sciences, to synergistically address our society’s challenge of antimicrobial resistance.

Presenter of 1 Presentation

HUMAN OTULIN HAPLOINSUFFICIENCY IMPAIRS CELL-INTRINSIC IMMUNITY TO STAPHYLOCOCCAL ΑLPHA-TOXIN

Session Type
Oral Communications
Date
Fri, 14.10.2022
Session Time
17:35 - 18:35
Room
Plenary Hall
Lecture Time
18:19 - 18:27

Abstract

Background and Aims

Staphylococcus aureus is a major bacterial pathogen with a global impact on human health. The molecular basis of interindividual clinical variability upon exposure to and infection with S. aureus is unclear. Most cases of severe staphylococcal disease remain unexplained.

Methods

We aimed to discover human genetic and immunological determinants of severe staphylococcal disease in a genome-wide manner. We tested for genetic homogeneity in a cohort of patients with unexplained life-threatening staphylococcal disease in the exomes of 105 cases and 1,274 controls.

Results

We found enrichment for rare heterozygous OTULIN variants in patients with severe staphylococcal disease. OTULIN is a linear deubiquitinase and negative regulator of NF-κB-signaling encoded by a gene on chromosome 5p. Probands heterozygous for deleterious OTULIN variants suffered from episodes of life-threatening skin or pulmonary necrosis. Their disease was typically triggered by S. aureus infections. Haploinsufficiency was the mechanism of dominance and was both biochemically and clinically phenocopied in patients with the more common 5p- (Cri-du-Chat) chromosomal deletion syndrome. Blood leukocyte subsets were developmentally and functionally unaffected. In dermal fibroblasts, OTULIN haploinsufficiency increased the levels of linear ubiquitin, but TNF-receptor NF-κB-signaling remained intact. The OTULIN-dependent accumulation of caveolin-1 in dermal fibroblasts — but not leukocytes — facilitated the cytotoxic damage inflicted by the staphylococcal virulence factor α-toxin. Naturally elicited antibodies against α-toxin contributed to incomplete clinical penetrance.

Conclusions

By disrupting cell-intrinsic immunity to α-toxin in fibroblasts, human OTULIN haploinsufficiency underlies life-threatening staphylococcal disease of the skin and lungs.

Hide